348 related articles for article (PubMed ID: 18236722)
21. Proceedings of the 2nd International Cytoprotection Investigators' Congress. June 6-9, 2002. St Thomas, US Virgin Islands, USA.
Semin Oncol; 2002 Dec; 29(6 Suppl 19):1-83. PubMed ID: 12577235
[No Abstract] [Full Text] [Related]
22. Studies on radioprotectors in mammals and their possible use in radiotherapy--a summary.
Kumar S
Radiobiol Radiother (Berl); 1985; 26(3):359-65. PubMed ID: 2997830
[No Abstract] [Full Text] [Related]
23. Pharmacologic normal tissue protection in clinical radiation oncology: focus on amifostine.
Mell LK; Movsas B
Expert Opin Drug Metab Toxicol; 2008 Oct; 4(10):1341-50. PubMed ID: 18798703
[TBL] [Abstract][Full Text] [Related]
24. [Effects of Pantosin on radiation therapy].
Tedo T
Iryo; 1969 Jul; 23(7):945-50. PubMed ID: 5353647
[No Abstract] [Full Text] [Related]
25. [Restorative inhibition of radiation injureis by chemical compounds as a method of increasing the effectiveness of the radiotherapy of tumors].
Pelevina II
Med Radiol (Mosk); 1977 Feb; 22(2):8-13. PubMed ID: 859396
[No Abstract] [Full Text] [Related]
26. The use of amifostine to prevent xerostomia in patients receiving radiation therapy.
Batcha M
Oncol Nurs Forum; 2000 May; 27(4):615-6. PubMed ID: 10833684
[No Abstract] [Full Text] [Related]
27. Normal tissue tolerance and damage.
Cancer; 1976 Apr; 37(4 Suppl):2046-55. PubMed ID: 1260701
[No Abstract] [Full Text] [Related]
28. [Development of cancer chemotherapy. Cytoprotective agents].
Lopez M
Clin Ter; 2001; 152(2):135-43. PubMed ID: 11441524
[No Abstract] [Full Text] [Related]
29. Recent developments and emerging options: the role of amifostine as a broad-spectrum cytoprotective agent.
Capizzi RL
Semin Oncol; 1999 Apr; 26(2 Suppl 7):1-2. PubMed ID: 10348254
[No Abstract] [Full Text] [Related]
30. [Optimal tumor therapy with cytoprotection by ETHYOL (Amifostine). 32nd Annual Session of the American Society of Clinical Oncology in Philadelphia 18-21 May 1996].
Dtsch Med Wochenschr; 1996 Sep; 121(36 Suppl Fur Die):1-6. PubMed ID: 9417379
[No Abstract] [Full Text] [Related]
31. [Amifostine: current and future applications in cytoprotection].
Lenoble M
Bull Cancer; 1996 Sep; 83(9):773-87. PubMed ID: 8952658
[TBL] [Abstract][Full Text] [Related]
32. Protection of normal tissue from the cytotoxic effects of chemotherapy and radiation by amifostine: clinical experiences.
Capizzi RL; Oster W
Eur J Cancer; 1995; 31A Suppl 1():S8-13. PubMed ID: 7577096
[TBL] [Abstract][Full Text] [Related]
33. Cytogenetic damage induced by radiotherapy. Evaluation of protection by amifostine and analysis of chromosome aberrations persistence.
Xunclà M; Barquinero JF; Caballín MR; Craven-Bartle J; Ribas M; de Vega JM; Barrios L
Int J Radiat Biol; 2008 Mar; 84(3):243-51. PubMed ID: 18300025
[TBL] [Abstract][Full Text] [Related]
34. Use of Amifostine for Cytoprotection during Radiation Therapy: A Review.
King M; Joseph S; Albert A; Thomas TV; Nittala MR; Woods WC; Vijayakumar S; Packianathan S
Oncology; 2020; 98(2):61-80. PubMed ID: 31846959
[TBL] [Abstract][Full Text] [Related]
35. Preventing or reducing late side effects of radiation therapy: radiobiology meets molecular pathology.
Bentzen SM
Nat Rev Cancer; 2006 Sep; 6(9):702-13. PubMed ID: 16929324
[TBL] [Abstract][Full Text] [Related]
36. The role of amifostine in the treatment of head and neck cancer with cisplatin-radiotherapy.
Marcu LG
Eur J Cancer Care (Engl); 2009 Mar; 18(2):116-23. PubMed ID: 19267726
[TBL] [Abstract][Full Text] [Related]
37. Amifostine: the first selective-target and broad-spectrum radioprotector.
Kouvaris JR; Kouloulias VE; Vlahos LJ
Oncologist; 2007 Jun; 12(6):738-47. PubMed ID: 17602063
[TBL] [Abstract][Full Text] [Related]
38. Future strategies for mitigation and treatment of chronic radiation-induced normal tissue injury.
Moulder JE; Cohen EP
Semin Radiat Oncol; 2007 Apr; 17(2):141-8. PubMed ID: 17395044
[TBL] [Abstract][Full Text] [Related]
39. Hypofractionated and accelerated radiotherapy with subcutaneous amifostine cytoprotection as short adjuvant regimen after breast-conserving surgery: interim report.
Koukourakis MI; Tsoutsou PG; Abatzoglou IM; Sismanidou K; Giatromanolaki A; Sivridis E
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1173-80. PubMed ID: 19058920
[TBL] [Abstract][Full Text] [Related]
40. Amifostine reduces side effects and improves complete response rate during radiotherapy: results of a meta-analysis.
Sasse AD; Clark LG; Sasse EC; Clark OA
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(3):784-91. PubMed ID: 16198504
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
